Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1994 Mar 1;150(5):681–686.

Cervicovaginal screening in women with HIV infection: a need for increased vigilance?

C A Hankins 1, J A Lamont 1, M A Handley 1
PMCID: PMC1486337  PMID: 8313287

Abstract

OBJECTIVE: To review the current literature on cervical disease (dysplasia, cervical intraepithelial neoplasia [CIN] or carcinoma) in women with HIV infection and to assess recommendations for cervicovaginal screening in these patients. DATA SOURCES: MEDLINE and AIDSLINE were searched for relevant articles published in English or French between January 1987 and February 1993, abstracts presented at international AIDS conferences from 1989 to 1993 were evaluated, and pertinent agencies and organizations were consulted. STUDY SELECTION: A total of 92 reports of gynecologic disease in women with HIV infection were examined; 32 studies were retained that reported pertinent findings on cervical dysplasia, CIN or cervical carcinoma. DATA EXTRACTION: The following criteria were used to extract data: study design (descriptive v. comparative), sample size, heterogeneity of the study population, presence of immunodeficiency indicators (i.e., absolute CD4+ lymphocyte count) and presence of concomitant vaginal infections. Recommendations were assessed for their specific application to women with HIV infection. DATA SYNTHESIS: Data on the associations between stage of cervical disease and response to treatment at varying levels of CD4+ lymphocyte depletion were incomplete. Recommendations by official bodies for cervicovaginal screening in women with HIV infection differed little from recommendations for standard care of all women of reproductive age. CONCLUSIONS: The consequences of a missed or delayed diagnosis of cervical disease for women with HIV infection can be severe. Pending further research, more frequent cervicovaginal screening through Papanicolaou testing and colposcopy in women with HIV infection is warranted.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biggar R. J. Cancer in acquired immunodeficiency syndrome: an epidemiological assessment. Semin Oncol. 1990 Jun;17(3):251–260. [PubMed] [Google Scholar]
  2. Burk R. D., Kadish A. S., Calderin S., Romney S. L. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear. Am J Obstet Gynecol. 1986 May;154(5):982–989. doi: 10.1016/0002-9378(86)90733-7. [DOI] [PubMed] [Google Scholar]
  3. Carpenter C. C., Mayer K. H., Stein M. D., Leibman B. D., Fisher A., Fiore T. C. Human immunodeficiency virus infection in North American women: experience with 200 cases and a review of the literature. Medicine (Baltimore) 1991 Sep;70(5):307–325. doi: 10.1097/00005792-199109000-00003. [DOI] [PubMed] [Google Scholar]
  4. Feingold A. R., Vermund S. H., Burk R. D., Kelley K. F., Schrager L. K., Schreiber K., Munk G., Friedland G. H., Klein R. S. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr. 1990;3(9):896–903. [PubMed] [Google Scholar]
  5. Gaudette L. A., Gao R. N., Freitag S., Wideman M. Cancer incidence by ethnic group in the Northwest Territories (NWT) 1969-1988. Health Rep. 1993;5(1):23–32. [PubMed] [Google Scholar]
  6. Johnson J. C., Burnett A. F., Willet G. D., Young M. A., Doniger J. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol. 1992 Mar;79(3):321–327. doi: 10.1097/00006250-199203000-00001. [DOI] [PubMed] [Google Scholar]
  7. Koutsky L. A., Galloway D. A., Holmes K. K. Epidemiology of genital human papillomavirus infection. Epidemiol Rev. 1988;10:122–163. doi: 10.1093/oxfordjournals.epirev.a036020. [DOI] [PubMed] [Google Scholar]
  8. Kreiss J. K., Kiviat N. B., Plummer F. A., Roberts P. L., Waiyaki P., Ngugi E., Holmes K. K. Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes. Sex Transm Dis. 1992 Jan-Feb;19(1):54–59. doi: 10.1097/00007435-199201000-00011. [DOI] [PubMed] [Google Scholar]
  9. Lungu O., Sun X. W., Felix J., Richart R. M., Silverstein S., Wright T. C., Jr Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA. 1992 May 13;267(18):2493–2496. [PubMed] [Google Scholar]
  10. Maiman M., Tarricone N., Vieira J., Suarez J., Serur E., Boyce J. G. Colposcopic evaluation of human immunodeficiency virus-seropositive women. Obstet Gynecol. 1991 Jul;78(1):84–88. [PubMed] [Google Scholar]
  11. Reeves W. C., Rawls W. E., Brinton L. A. Epidemiology of genital papillomaviruses and cervical cancer. Rev Infect Dis. 1989 May-Jun;11(3):426–439. doi: 10.1093/clinids/11.3.426. [DOI] [PubMed] [Google Scholar]
  12. Rellihan M. A., Dooley D. P., Burke T. W., Berkland M. E., Longfield R. N. Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol Oncol. 1990 Mar;36(3):435–438. doi: 10.1016/0090-8258(90)90159-i. [DOI] [PubMed] [Google Scholar]
  13. Schwartz L. B., Carcangiu M. L., Bradham L., Schwartz P. E. Rapidly progressive squamous cell carcinoma of the cervix coexisting with human immunodeficiency virus infection: clinical opinion. Gynecol Oncol. 1991 Jun;41(3):255–258. doi: 10.1016/0090-8258(91)90319-z. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES